Receive the latest updates from Matrix Medical in real time to understand product information.

On the morning of February 20, 2025, Director Li Yaohua and his delegation from the Medical Device Yangtze River Delta Branch of the National Medical Products Administration, accompanied by Director Zhang Haijun of the Zhejiang Provincial Medical Products Administration and other relevant responsible persons from provincial and municipal regulatory departments, went to Hangzhou Matrix Medical Technology Co., Ltd. (hereinafter referred to as' Matrix Medical ') for on-site inspection and research activities. The purpose of this research activity is to gain a deeper understanding of the current development status, characteristics, and needs of innovative medical devices in Zhejiang Province, in order to provide more accurate and precise service guidance for their innovative development.

During the research process, Director Li Yaohua and his delegation visited the product exhibition hall and R&D laboratory of Matrix Medical, and gained a detailed understanding of the latest developments in technological innovation, product research and development, and market layout of Juzheng Medical. They highly recognized the company's concept of "involvement without implantation" and its ability to innovate in product research and development.

Founder of Matrix Medical, Ji Peihong, introduces the company's products to Director Li Yaohua and his delegation at the National Bureau of Health

At the symposium, the relevant person in charge of Matrix Medical reported on the research and development status of the company's main products and the product application plan, and looked forward to the next stage of work blueprint. Experts from the evaluation department of the Yangtze River Delta sub center had in-depth discussions with company leaders on specific issues encountered during the device registration application process, and provided detailed and clear answers to difficult questions.

Ji Peihong, founder and CEO of Matrix Medical, expressed great gratitude to the leaders of the National Medical Products Administration and provincial and municipal regulatory departments for their attention and recognition of the company. This visit and research by the National Medical Products Administration is not only a high level of attention and support for Matrix Medical's work, but also injects strong impetus into the company's development. Matrix Medical will take this opportunity to closely align with the national strategic deployment, continuously enhance its own strength, and adhere to product research and development innovation. With the care and support of the leaders of the Drug Administration, we look forward to achieving even better results and contributing more to the healthcare industry in Yuhang District.